Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia

被引：3
|
作者：
Robinson, Troy [1 ,2 ]
Bowman, Robert L. [2 ,3 ]
Persaud, Sonali [2 ]
Liu, Ying [4 ,5 ]
Gao, Qi [6 ]
Zhang, Jing-Ping [7 ]
Sun, Xiaotian [6 ]
Sciambi, Adam [8 ]
Llanso, Aaron [9 ]
Famulare, Christopher [10 ]
Goldberg, Aaron D. [11 ]
Dogan, Ahmet [6 ]
Roshal, Mikhail [6 ]
Levine, Ross L. [2 ,10 ,11 ,12 ]
Xiao, Wenbin [2 ,6 ,10 ]
机构：
[1] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, New York, NY 10021 USA
[4] Mem Sloan Kettering, Hematopathol Serv, Dept Pathol & Lab Med, New York, NY USA
[5] Mem Sloan Kettering, Mol Diagnost Serv, Dept Pathol & Lab Med, New York, NY USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, New York, NY USA
[7] Mem Sloan Kettering Canc Ctr, Dept Pathol, Hematopathol Serv, New York, NY 10021 USA
[8] Mission Bio Inc, San Francisco, CA USA
[9] Mission Bio, San Francisco, CA USA
[10] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, New York, NY 10021 USA
[11] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
[12] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166501
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2275 / 2277
页数：3
相关论文
共 50 条
  • [31] Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations
    Walter, Roland B.
    Ofran, Yishai
    Wierzbowska, Agnieszka
    Ravandi, Farhad
    Hourigan, Christopher S.
    Ngai, Lok Lam
    Venditti, Adriano
    Buccisano, Francesco
    Ossenkoppele, Gert J.
    Roboz, Gail J.
    LEUKEMIA, 2021, 35 (06) : 1529 - 1538
  • [32] Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns
    Tanja Božić
    Chao-Chung Kuo
    Jan Hapala
    Julia Franzen
    Monika Eipel
    Uwe Platzbecker
    Martin Kirschner
    Fabian Beier
    Edgar Jost
    Christian Thiede
    Wolfgang Wagner
    Leukemia, 2022, 36 : 80 - 89
  • [33] CLINICAL IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA (AML)
    Venditti, A.
    Buzzatti, E.
    Guarnera, L.
    Bonanni, F.
    Moretti, F.
    Pascale, M. R.
    Mallegni, F.
    Palmieri, R.
    Paterno, G.
    Del Principe, M. I.
    Maurillo, L.
    Voso, M. T.
    Buccisano, F.
    HAEMATOLOGICA, 2021, 106 (10) : 202 - 205
  • [34] Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia
    Yoest, Jennifer M.
    Shirai, Cara Lunn
    Duncavage, Eric J.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [35] Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection
    Rajsri, Kritika Srinivasan
    Roy, Nainita
    Chakraborty, Sohini
    CANCERS, 2023, 15 (10)
  • [36] Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia
    Castellet, Helena
    Ramil, Guillermo
    Carricondo, Maite
    Onate, Guadalupe
    Garrido, Ana
    Artigas, Alicia
    Pratcorona, Marta
    Salamero, Olga
    Cortes-Bullich, Albert
    Vives, Susana
    Tormo, Mar
    Mascaro, Marti
    Gallardo, David
    Tutusaus, Josep Maria Marti
    Garcia, Antonio
    Sierra, Jorge
    Esteve, Jordi
    Nomdedeu, Josep
    CETLAM Grp
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [37] Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Stahl, Maximilian
    Derkach, Andriy
    Farnoud, Noushin
    Bewersdorf, Jan Philipp
    Robinson, Troy
    Famulare, Christopher
    Cho, Christina
    Devlin, Sean
    Menghrajani, Kamal
    Patel, Minal A.
    Cai, Sheng F.
    Miles, Linde A.
    Bowman, Robert L.
    Geyer, Mark B.
    Dunbar, Andrew
    Epstein-Peterson, Zachary D.
    McGovern, Erin
    Schulman, Jessica
    Glass, Jacob L.
    Taylor, Justin
    Viny, Aaron D.
    Stein, Eytan M.
    Getta, Bartlomiej
    Arcila, Maria E.
    Gao, Qi
    Barker, Juliet
    Shaffer, Brian C.
    Papadopoulos, Esperanza B.
    Gyurkocza, Boglarka
    Perales, Miguel-Angel
    Abdel-Wahab, Omar
    Levine, Ross L.
    Giralt, Sergio A.
    Zhang, Yanming
    Xiao, Wenbin
    Pai, Nidhi
    Papaemmanuil, Elli
    Tallman, Martin S.
    Roshal, Mikhail
    Goldberg, Aaron D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (01) : 79 - 89
  • [38] Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations
    Roland B. Walter
    Yishai Ofran
    Agnieszka Wierzbowska
    Farhad Ravandi
    Christopher S. Hourigan
    Lok Lam Ngai
    Adriano Venditti
    Francesco Buccisano
    Gert J. Ossenkoppele
    Gail J. Roboz
    Leukemia, 2021, 35 : 1529 - 1538
  • [39] Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia
    Wong, Zoe C.
    Dillon, Laura W.
    Hourigan, Christopher S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2023, 36 (02)
  • [40] Detection methods and prognosis implications of measurable residual disease in acute myeloid leukemia
    Zhao, Zihan
    Lan, Jianping
    ANNALS OF HEMATOLOGY, 2024, 103 (12) : 4869 - 4881
12345